Market Tracker

02/11 4:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.85
Delayed Data
As of 4:00pm ET
 +0.17 / +2.99%
Today’s Change
5.14
Today|||52-Week Range
21.22
-32.91%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close5.68
Today’s open5.55
Day’s range5.50 - 5.99
Volume427,820
Average volume (3 months)477,406
Market cap$297.3M
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+7.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book2.11

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...-0.07-1.58%
----
CNCEConcert Pharmaceutic...-0.09-0.68%
ADMSAdamas Pharmaceutica...-0.07-0.52%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
Chief Operating, Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts